Rimmelzwaan GF - Search Results

1

Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head.

Wiersma LC, Rimmelzwaan GF, de Vries RD. Wiersma LC, et al. Among authors: rimmelzwaan gf. Vaccines (Basel). 2015 Mar 26;3(2):239-62. doi: 10.3390/vaccines3020239. Vaccines (Basel). 2015. PMID: 26343187 Free PMC article. Review.

2

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF. Kreijtz JH, et al. Among authors: rimmelzwaan gf. Hum Vaccin. 2009 Mar;5(3):126-35. doi: 10.4161/hv.5.3.6986. Epub 2009 Mar 15. Hum Vaccin. 2009. PMID: 18948744 Review.

3

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.

Rimmelzwaan GF, Sutter G. Rimmelzwaan GF, et al. Expert Rev Vaccines. 2009 Apr;8(4):447-54. doi: 10.1586/erv.09.4. Expert Rev Vaccines. 2009. PMID: 19348560 Free PMC article. Review.

4

Animal models for the preclinical evaluation of candidate influenza vaccines.

Bodewes R, Rimmelzwaan GF, Osterhaus AD. Bodewes R, et al. Among authors: rimmelzwaan gf. Expert Rev Vaccines. 2010 Jan;9(1):59-72. doi: 10.1586/erv.09.148. Expert Rev Vaccines. 2010. PMID: 20021306 Review.

5

Towards universal influenza vaccines?

Osterhaus A, Fouchier R, Rimmelzwaan G. Osterhaus A, et al. Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2766-73. doi: 10.1098/rstb.2011.0102. Philos Trans R Soc Lond B Biol Sci. 2011. PMID: 21893539 Free PMC article.

6

Developing vaccines against virus infections: between hope and fear.

Rimmelzwaan GF. Rimmelzwaan GF. Hum Vaccin Immunother. 2012 Mar;8(3):286-8. doi: 10.4161/hv.19935. Epub 2012 Mar 1. Hum Vaccin Immunother. 2012. PMID: 22418876

7

Pediatric influenza vaccination: understanding the T-cell response.

Bodewes R, Fraaij PL, Osterhaus AD, Rimmelzwaan GF. Bodewes R, et al. Among authors: rimmelzwaan gf. Expert Rev Vaccines. 2012 Aug;11(8):963-71. doi: 10.1586/erv.12.69. Expert Rev Vaccines. 2012. PMID: 23002977 Review.

8

Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.

Altenburg AF, Kreijtz JH, de Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A. Altenburg AF, et al. Among authors: rimmelzwaan gf. Viruses. 2014 Jul 17;6(7):2735-61. doi: 10.3390/v6072735. Viruses. 2014. PMID: 25036462 Free PMC article. Review.

9

A single immunization with modified vaccinia virus Ankara-based influenza virus H7 vaccine affords protection in the influenza A(H7N9) pneumonia ferret model.

Kreijtz JH, Wiersma LC, De Gruyter HL, Vogelzang-van Trierum SE, van Amerongen G, Stittelaar KJ, Fouchier RA, Osterhaus AD, Sutter G, Rimmelzwaan GF. Kreijtz JH, et al. Among authors: rimmelzwaan gf. J Infect Dis. 2015 Mar 1;211(5):791-800. doi: 10.1093/infdis/jiu528. Epub 2014 Sep 22. J Infect Dis. 2015. PMID: 25246535 Free PMC article.

10

Virus-specific T cells as correlate of (cross-)protective immunity against influenza.

Altenburg AF, Rimmelzwaan GF, de Vries RD. Altenburg AF, et al. Among authors: rimmelzwaan gf. Vaccine. 2015 Jan 15;33(4):500-6. doi: 10.1016/j.vaccine.2014.11.054. Epub 2014 Dec 9. Vaccine. 2015. PMID: 25498210 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page